<?xml version="1.0" encoding="UTF-8"?>
<p>Prabhu et al. synthesised and studied the anticancer activities of oxothiazolidine based BTA derivatives. The substituted chlorophenyl oxothiazolidine based benzothiazole 
 <bold>53</bold> (
 <xref ref-type="fig" rid="F0033">Figure 33</xref>) showed the most effective anticancer activity against HeLa cell line, inducing 96.8% inhibition and IC
 <sub>50</sub> value of 9.76 µM, when compared with the reference drug cisplatin
 <xref rid="CIT0054" ref-type="bibr">
  <sup>54</sup>
 </xref>.
</p>
